Marilyn C. Darkes - Concepedia

Concepedia

Author

Marilyn C. Darkes

Rega Institute for Medical Research

Also Known As

Darkes, M.C., M C Darkes, M.C. Darkes, Marilyn C. Darkes, Marilyn Darkes

22

Publications

1.2K

Citations

15

H-Index

41

Concepts

All Affiliations

Rega Institute for Medical Research Trinity Western University Syracuse University University of Essex AnMed Health

MC

About

Marilyn C. Darkes is an author at Rega Institute for Medical Research specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	452
2	Engineering	2	2	97
3	Biochemistry	2	2	45
4	Natural Sciences	1	1	16
5	Biomolecular Engineering	1	1	14

Marilyn C. Darkes

×

16

Publications

1.2K

Citations

15

H-Index

	Year	Citations
<i>In vivo</i> detection and imaging of phosphatidylserine expression during programmed cell death Francis G. Blankenberg, Peter D. Katsikis, Jonathan F. Tait, Proceedings of the National Academy of Sciences	1998	538
Characterization of the molecular pharmacology of AMD3100: A specific antagonist of the G-protein coupled chemokine receptor, CXCR4 Simon P. Fricker, Virginia Anastassov, Jennifer H. Cox, Biochemical Pharmacology Molecular PharmacologyChemokine ReceptorSpecific AntagonistG Protein-coupled ReceptorMedicine	2006	216
Pharmacology of AMD3465: A small molecule antagonist of the chemokine receptor CXCR4 V. Bodart, Virginia Anastassov, Marilyn C. Darkes, Biochemical Pharmacology Molecular PharmacologySmall Molecule AntagonistMedicineImmunologyMechanism Of Action	2009	55
Ruthenium(III) Polyaminocarboxylate Complexes: Efficient and Effective Nitric Oxide Scavengers Beth R. Cameron, Marilyn C. Darkes, Helen S. Yee, Inorganic Chemistry Inorganic ChemistryChemical EngineeringEngineeringPolyaminocarboxylate ComplexesNitric Oxide	2003	55
The molecular pharmacology of AMD11070: An orally bioavailable CXCR4 HIV entry inhibitor Renée Mosi, Virginia Anastassova, Jennifer H. Cox, Biochemical Pharmacology Molecular PharmacologyMedicineHuman RetrovirusAntiviral TherapyPharmacotherapy	2011	52
Convenient Synthesis of Water Soluble, Isomerically Pure Ruthenium Phthalocyanine Complexes Gerald E. Bossard, Michael J. Abrams, Marilyn C. Darkes, Inorganic Chemistry Inorganic ChemistryChemical EngineeringMolecular SciencesEngineeringChemical Measurement	1995	42
Ruthenium(III) Triazacyclononane Dithiocarbamate, Pyridinecarboxylate, or Aminocarboxylate Complexes as Scavengers of Nitric Oxide Beth R. Cameron, Marilyn C. Darkes, Ian R. Baird, Inorganic Chemistry	2003	41
Mechanistic Studies on AMD6221: A Ruthenium-Based Nitric Oxide Scavenger Renée Mosi, Béatrice Séguin, Beth R. Cameron, Biochemical and Biophysical Research Communications Mechanistic StudiesReactive Nitrogen SpecieHydrogenChemistryRedox Biology	2002	35
A Ruthenium (III) Polyaminocarboxylate Complex, A Novel Nitric Oxide Scavenger, Enhances Graft Survival and Decreases Nitrosylated Heme Protein in Models of Acute and Delayed Cardiac Transplant Rejection Galen M. Pieper, Allan M. Roza, Mark B. Adams, Journal of Cardiovascular Pharmacology Heart FailureNitric OxideEnhances Graft SurvivalImmunologyOxidative Stress	2002	32
Pharmacokinetics of antiviral polyoxometalates in rats Lan Ni, F. Douglas Boudinot, Sally G. Boudinot, Antimicrobial Agents and Chemotherapy Antiviral CompoundBiochemistryPharmacologyAntiviral Drug DevelopmentAntiviral Therapy	1994	29

Page 1